Td Private Client Wealth LLC Roivant Sciences Ltd. Transaction History
Td Private Client Wealth LLC
- $4.07 Trillion
- Q2 2025
A detailed history of Td Private Client Wealth LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 820 shares of ROIV stock, worth $9,364. This represents 0.0% of its overall portfolio holdings.
Number of Shares
820
Previous 454
80.62%
Holding current value
$9,364
Previous $4.58 Million
101.72%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ROIV
# of Institutions
335Shares Held
495MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$751 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$706 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$525 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$466 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$410 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.04B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...